Cargando…
The “Connection” Between HIV Drug Resistance and RNase H
Currently, nucleoside reverse transcriptase inhibitors (NRTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) are two classes of antiretroviral agents that are approved for treatment of HIV-1 infection. Since both NRTIs and NNRTIs target the polymerase (pol) domain of reverse transcript...
Autores principales: | Delviks-Frankenberry, Krista A., Nikolenko, Galina N., Pathak, Vinay K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982141/ https://www.ncbi.nlm.nih.gov/pubmed/21088701 http://dx.doi.org/10.3390/v2071476 |
Ejemplares similares
-
Structural Insights into APOBEC3-Mediated Lentiviral Restriction
por: Delviks-Frankenberry, Krista A., et al.
Publicado: (2020) -
Lack of Detection of Xenotropic Murine Leukemia Virus-Related Virus in HIV-1 Lymphoma Patients
por: Delviks-Frankenberry, Krista A., et al.
Publicado: (2011) -
Mechanisms and Factors that Influence High Frequency Retroviral Recombination
por: Delviks-Frankenberry, Krista, et al.
Publicado: (2011) -
Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G
por: Delviks-Frankenberry, Krista A., et al.
Publicado: (2023) -
Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G
por: Delviks-Frankenberry, Krista A., et al.
Publicado: (2019)